$683.09 Million in Sales Expected for Mettler-Toledo International, Inc. (NYSE:MTD) This Quarter

Brokerages predict that Mettler-Toledo International, Inc. (NYSE:MTD) will post sales of $683.09 million for the current fiscal quarter, according to Zacks Investment Research. Six analysts have issued estimates for Mettler-Toledo International’s earnings, with the highest sales estimate coming in at $685.25 million and the lowest estimate coming in at $680.00 million. Mettler-Toledo International reported sales of $650.60 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 5%. The company is expected to issue its next earnings results on Thursday, November 2nd.

On average, analysts expect that Mettler-Toledo International will report full-year sales of $683.09 million for the current year, with estimates ranging from $2.68 billion to $2.70 billion. For the next financial year, analysts anticipate that the business will report sales of $2.85 billion per share, with estimates ranging from $2.83 billion to $2.88 billion. Zacks’ sales calculations are a mean average based on a survey of analysts that that provide coverage for Mettler-Toledo International.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, July 27th. The medical instruments supplier reported $3.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.89 by $0.03. The business had revenue of $653.70 million during the quarter, compared to the consensus estimate of $646.68 million. Mettler-Toledo International had a return on equity of 95.28% and a net margin of 16.60%. The business’s revenue was up 7.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.22 EPS.

Several analysts have recently weighed in on the company. Jefferies Group LLC restated a “hold” rating and issued a $550.00 price objective on shares of Mettler-Toledo International in a report on Thursday, July 27th. BidaskClub lowered Mettler-Toledo International from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Zacks Investment Research upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating and set a $655.00 price objective for the company in a report on Wednesday, June 14th. Finally, Morgan Stanley restated an “equal weight” rating and issued a $565.00 price objective (up previously from $533.00) on shares of Mettler-Toledo International in a report on Saturday, July 22nd. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $569.80.

Mettler-Toledo International (MTD) traded down 0.18% on Thursday, hitting $576.61. The stock had a trading volume of 120,911 shares. Mettler-Toledo International has a one year low of $386.01 and a one year high of $618.13. The company has a market cap of $14.80 billion, a PE ratio of 35.46 and a beta of 1.13. The stock has a 50-day moving average of $594.32 and a 200-day moving average of $522.25.

In other news, Director Robert F. Spoerry sold 4,000 shares of the company’s stock in a transaction on Tuesday, May 9th. The stock was sold at an average price of $545.15, for a total transaction of $2,180,600.00. Following the completion of the sale, the director now directly owns 9,287 shares of the company’s stock, valued at $5,062,808.05. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider William P. Donnelly sold 5,000 shares of the company’s stock in a transaction on Tuesday, May 9th. The shares were sold at an average price of $546.18, for a total value of $2,730,900.00. Following the sale, the insider now directly owns 3,000 shares of the company’s stock, valued at $1,638,540. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 54,891 shares of company stock valued at $30,468,039. 5.20% of the stock is currently owned by company insiders.

Large investors have recently made changes to their positions in the stock. Oliver Luxxe Assets LLC bought a new stake in shares of Mettler-Toledo International during the first quarter valued at approximately $216,000. Atria Investments LLC raised its position in Mettler-Toledo International by 12.2% in the first quarter. Atria Investments LLC now owns 1,139 shares of the medical instruments supplier’s stock valued at $545,000 after buying an additional 124 shares during the last quarter. Highland Capital Management LLC acquired a new position in Mettler-Toledo International during the first quarter valued at $299,000. Legacy Private Trust Co. raised its position in Mettler-Toledo International by 3.4% in the first quarter. Legacy Private Trust Co. now owns 10,049 shares of the medical instruments supplier’s stock valued at $4,813,000 after buying an additional 327 shares during the last quarter. Finally, Gulf International Bank UK Ltd raised its position in Mettler-Toledo International by 1.4% in the first quarter. Gulf International Bank UK Ltd now owns 8,168 shares of the medical instruments supplier’s stock valued at $3,911,000 after buying an additional 110 shares during the last quarter. 95.72% of the stock is owned by institutional investors and hedge funds.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.

Get a free copy of the Zacks research report on Mettler-Toledo International (MTD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com